Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat- activated transcription of the HIV-1 long terminal repeat

Virology

Volumn 268, Issue 2, 2000, Pages 452-460

  Zhou, Meisheng ^a   Kashanchi, Fatah ^a   Jiang, Hua ^a   Ge, Hui ^b   Brady, John N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SUBUNIT; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034654351     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0177     Document Type: Article

References (62)

1. Aso T., Vasavada H. A., Kawaguchi T., Germino F. J., Ganguly S., Kitajima S., Weissman S. M., Yasukochi Y. Characterization of cDNA for the large subunit of the transcription initiation factor TFIIF. Nature. 355:1992;461-464.
2. Berkhout B., Silverman R. H., Jeang K. T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell. 59:1989;273-282.
3. Bieniasz P. D., Grdina T. A., Bogerd H. P., Cullen B. R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:1998;7056-7065.
4. Bieniasz P. D., Grdina T. A., Bogerd H. P., Cullen B. R. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA. 96:1999;7791-7796.
5. Bohan C. A., Kashanchi F., Ensoli B., Buonaguro L., Boris-Lawrie K. A., Brady J. N. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 2:1992;391-407.
6. Boris-Lawrie K. A., Brady J. N., Kumar A. Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. Gene Expr. 2:1992;215-230.
7. Chambers R. S., Wang B. Q., Burton Z. F., Dahmus M. E. The activity of COOH-terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors IIF and IIB. J. Biol. Chem. 270:1995;14962-14969.
8. Chang C., Kostrub C. F., Burton Z. F. RAP30/74 (transcription factor IIF) is required for promoter escape by RNA polymerase II. J. Biol. Chem. 268:1993;20482-20489.
9. Cujec T. P., Cho H., Maldonado E., Meyer J., Reinberg D., Peterlin B. M. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1997a;1817-1823.
10. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997b;2645-2657.
11. Cullen B. R. Does HIV-1 Tat induce a change in viral initiation rights. Cell. 73:1993;417-420.
12. Dikstein R., Ruppert S., Tjian R. TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74. Cell. 84:1996;781-790.
13. Feinberg M. B., Baltimore D., Frankel A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA. 88:1991;4045-4049.
14. Finkelstein A., Kostrub C. F., Li J., Chavez D. P., Wang B. Q., Fang S. M., Greenblatt J., Burton Z. F. A cDNA encoding RAP74, a general initiation factor for transcription by RNA polymerase II. Nature. 355:1992;464-467.
15. Fujinaga K., Cujec T. P., Peng J., Garriga J., Price D. H., Grana X., Peterlin B. M. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:1998;7154-7159.
16. Fujinaga K., Taube R., Wimmer J., Cujec T. P., Peterlin B. M. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA. 96:1999;1285-1290.
17. Garber M. E., Jones K. A. HIV-1 Tat: Coping with negative elongation factors. Curr. Opin. Immunol. 11:1999;460-465.
18. Garber M. E., Wei P., KewalRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527.
19. Garcia-Martinez L. F., Ivanov D., Gaynor R. B. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272:1997;6951-6958.
20. Gaynor R. B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:1995;51-77.
21. Goodrich J. A., Tjian R. TBP-TAF complexes: Selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6:1994;403-409.
22. Hisatake K., Hasegawa S., Takada R., Nakatani Y., Horikoshi M., Roeder R. G. The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1. Nature. 362:1993;179-181.
23. Imhof A., Yang X.-J., Ogryzko V. V., Nakatani Y., Wolffe A. P., Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:1997;689-692.
24. Isel C., Karn J. Direct evidence that HIV-1 tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J. Mol. Biol. 290:1999;929-941.
25. Jeang K. T., Xiao H., Rich E. A. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274:1999;28837-28840.
26. Jones K. A. Taking a new TAK on tat transactivation. Genes Dev. 11:1997;2593-2599.
27. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
28. Kao S. Y., Calman A. F., Luciw P. A., Peterlin B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 330:1987;489-493.
29. Karn J. Tackling Tat. J. Mol. Biol. 293:1999;235-254.
30. Kashanchi F., Piras G., Radonovich M. F., Duvall J. F., Fattaey A., Chiang C. M., Roeder R. G., Brady J. N. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature. 367:1994;295-299.
31. Kato H., Sumimoto H., Pognonec P., Chen C. H., Rosen C. A., Roeder R. G. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:1992;655-666.
32. Kitajima S., Chibazakura T., Yonaha M., Yasukochi Y. Regulation of the human general transcription initiation factor TFIIF by phosphorylation. J. Biol. Chem. 269:1994;29970-29977.
33. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 59:1989;283-292.
34. Lei L., Ren D., Finkelstein A., Burton Z. F. Functions of the N- and C-terminal domains of human RAP74 in transcriptional initiation, elongation, and recycling of RNA polymerase II. Mol. Cell. Biol. 18:1998;2130-2142.
35. Majello B., Napolitano G., Giordano A., Lania L. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene. 18:1999;4598-4605.
36. Majello B., Napolitano G., Lania L. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation. AIDS. 12:1998;1957-1964.
37. Mancebo H. S., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
38. Marciniak R. A., Calnan B. J., Frankel A. D., Sharp P. A. HIV-1 Tat protein trans-activates transcription in vitro. Cell. 63:1990;791-802.
39. Mavankal G., Ignatius O. S., Oliver H., Sigman D., Gaynor R. B. Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. USA. 93:1996;2089-2094.
40. Mizzen C. A., Yang X. J., Kokubo T., Brownell J. E., Bannister A. J., Owen-Hughes T., Workman J., Wang L., Berger S. L., Kouzarides T., Nakatani Y., Allis C. D. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell. 87:1996;1261-1270.
41. O'Brien T., Tjian R. Functional analysis of the human TAFII250 N-terminal kinase domain. Mol. Cell. 1:1998;905-911.
42. Okamoto H., Sheline C. T., Corden J. L., Jones K. A., Peterlin B. M. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA. 93:1996;11575-11579.
43. Orphanides G., Lagrange T., Reinberg D. The general transcription factors of RNA polymerase II. Genes Dev. 10:1996;2657-2683.
44. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
45. Pendergrast P. S., Morrison D., Tansey W. P., Hernandez N. Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly. J. Virol. 70:1996;5025-5034.
46. Ratnasabapathy R., Sheldon M., Johal L., Hernandez N. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:1990;2061-2074.
47. Ruppert S., Wang E. H., Tjian R. Cloning and expression of human TAFII250: A TBP-associated factor implicated in cell-cycle regulation. Nature. 362:1993;175-179.
48. Sauer F., Hansen S. K., Tjian R. Multiple TAFIIs directing synergistic activation of transcription. Science. 270:1995;1783-1788.
49. Verrijzer C. P., Chen J. L., Yokomori K., Tjian R. Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell. 81:1995;1115-1125.
50. Verrijzer C. P., Tjian R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21:1996;338-342.
51. Wang B. Q., Burton Z. F. Functional domains of human RAP74 including a masked polymerase binding domain. J. Biol. Chem. 270:1995;27035-27044.
52. Wang E. H., Tjian R. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science. 263:1994;811-814.
53. Wang E. H., Zou S., Tjian R. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev. 11:1997;2658-2669.
54. Wei P., Garber M. E., Fang S. M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
55. Weinzierl R. O., Dynlacht B. D., Tjian R. Largest subunit of Drosophila transcription factor IID directs assembly of a complex containing TBP and a coactivator. Nature. 362:1993;511-517.
56. Weissman J. D., Brown J. A., Howcroft T. K., Hwang J., Chawla A., Roche P. A., Schlitz L., Nakatani Y., Singer D. S. HIV-1 Tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc. Natl. Acad. Sci. USA. 95:1998;11601-11606.
57. Wimmer J., Fujinaga K., Taube R., Cujec T. P., Zhu Y., Peng J., Price D. H., Peterlin B. M. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology. 255:1999;182-189.
58. Yonaha M., Aso T., Kobayashi Y., Vasavada H., Yasukochi Y., Weissman S. M., Kitajima S. Domain structure of a human general transcription initiation factor, TFIIF. Nucleic. Acids Res. 21:1993;273-279.
59. Yonaha M., Tsuchiya T., Yasukochi Y. Cell-cycle-dependent phosphorylation of the basal transcription factor RAP74. FEBS Lett. 410:1997;477-480.
60. Zawel L., Kumar K. P., Reinberg D. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev. 9:1995;1479-1490.
61. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;3681-3691.
62. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.